Intervention: Interferon Beta-1A

DisCoVeRy

Austria Belgium France Greece Luxembourg Norway Portugal
|
2020-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Remdesivir
  • Tixagevimab/Cilgavimab
  • Hydroxychloroquine
  • Interferon Beta-1A
  • Lopinavir/ritonavir